Products

What will AGI do for Alprenolol?

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 877K5MQ27W, chemically known as 2-propanol, 1-(o-allylphenoxy)-3-(isopropylamino)- but generally known as alprenolol, which bears US NIH Compound Identifier 2119. Alprenolol most often comes in glucuronide and hydrochloride forms. European Medicines Agency schedules Alprenolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05371MIG. The term ALPRENOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules alprenolol in its Anatomical Therapeutic Chemical (ATC) Classification. ALPRENOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alprenolol under HS 29221980 and SITC 51461. As of Q4 2014, ALPRENOLOL remains the US FDA Preferred Term for this commodity. Alprenolol bears US NLM identifiers UMLS ID C0002334 and NCI Concept Code C81653. SMILES: O(CC(O)CNC(C)C)C1C(CC=C)CCCC1.